CAMBRIDGE GENE THERAPY LIMITED
is not in process of liquidation on Jun 1, 2024
Private limited company
United Kingdom • 14 Dec 2017 (7 years ago)
Summary
- Active
United Kingdom
11112130- Primary:
- #7211 - Research and experimental development on biotechnology
Contact details
Officers
United Kingdom
Person with significant control
Appointed on14 Dec 2017
Country of residenceUnited Kingdom
United Kingdom
Director
Appointed on14 Dec 2017
Country of residenceUnited Kingdom
United Kingdom
Director
Appointed on14 Dec 2017
Country of residenceUnited Kingdom
Cyprus
Person with significant control
Appointed on14 Dec 2017
Country of residenceUnited Kingdom
Financial reports
Find out all the information about the company
Get full access to the data
Additional data
- First accounts made up to31 Dec 2023
due by 30 Sep 2024 - Last accounts made up to31 Dec 2022
- CategoryDORMANT
- Next statement date02 Sep 2024
due by 16 Sep 2024 - Last statement dated02 Sep 2023
- Next returns datedue by 11 Jan 2019
Related companies by officers
Frequently asked questions
Where is CAMBRIDGE GENE THERAPY LIMITED's headquarters?
CAMBRIDGE GENE THERAPY LIMITED's headquarters is located at ENGLAND, CAMBRIDGE, 102 STURTON STREET, CB1 2QF
What is CAMBRIDGE GENE THERAPY LIMITED's industry?
CAMBRIDGE GENE THERAPY LIMITED is in the industry of Research and experimental development on biotechnology
What year was CAMBRIDGE GENE THERAPY LIMITED started?
CAMBRIDGE GENE THERAPY LIMITED was started in 2017
Sources: Companies House
Your trusted source for business data
English, USA